(Q44335667)

2 December 2017

title

Estradiol promotes growth and angiogenesis in polyoma middle T transgenic mouse mammary tumor explants (English)

1 reference

2 December 2017

Charlotta Dabrosin

1

1 reference

2 December 2017

Kay Palmer

series ordinal

2

1 reference

2 December 2017

William J Muller

series ordinal

3

1 reference

2 December 2017

Jack Gauldie

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Breast Cancer Research and Treatment

2 December 2017

published in

1 reference

2 December 2017

volume

78

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

1-6

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1022133219353

2 December 2017

exact match

0 references

cites work

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

Estrogenic and antiestrogenic down-regulation of estrogen receptor levels: evidence for two different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

Estrogen and angiogenesis: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

Breast cancer: cause and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

Breast cancer risk associated with gynecologic surgery and indications for such surgery

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

The loss of estrogen and progesterone receptor gene expression in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

Clinical studies of angiogenesis inhibitors: the University of Texas MD Anderson Center Trial of Human Endostatin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

Multihormone regulation of MMTV-LTR in transfected T-47-D human breast cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

Antiangiogenic therapy of transgenic mice impairs de novo tumor growth

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022133219353

7 January 2021

Identifiers

DOI

10.1023/A:1022133219353

1 reference

Dimensions Publication ID

2 December 2017

1046090711

0 references

1 reference